Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. The Associate Director, Market Access Analytics, reporting to the Senior Director, Patient Services and Market Access Analytics, will lead the development of analytic strategy, reporting infrastructure, and insight generation to optimize payer access, pull-through performance, and pricing and contracting decisions. This role is a critical partner to Market Access Strategy, National and Regional Accounts, Trade, Patient Services, and Field Reimbursement teams—delivering actionable, data-driven insights that shape contracting strategies, access initiatives, and patient affordability programs. The ideal candidate combines deep expertise in pharmaceutical market access analytics with strong technical capabilities, business acumen, and an ability to translate complex data into meaningful, strategic recommendations for senior leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees